Your browser doesn't support javascript.
loading
4-1BB-4-1BBL cis-interaction contributes to the survival of self-reactive CD8+ T cell.
Cho, Eunjung; Singh, Rohit; Han, Chungyong; Kim, Seon-Hee; Kim, Kwang H; Park, Bo-Mi; Shin, Dong Hoon; Han, Seongeun; Kim, Young H; Kwon, Byoung S; Nam, Ki Taek; Choi, Beom K.
Afiliação
  • Cho E; Immuno-oncology Branch, Division of Rare and Refractory Cancer, National Cancer Center, Goyang, 10408, Republic of Korea.
  • Singh R; Severance Biomedical Science Institute, Brain Korea 21 Project for Medical Science, Yonsei University College of Medicine, Seoul, Republic of Korea.
  • Han C; Immuno-oncology Branch, Division of Rare and Refractory Cancer, National Cancer Center, Goyang, 10408, Republic of Korea.
  • Kim SH; Immuno-oncology Branch, Division of Rare and Refractory Cancer, National Cancer Center, Goyang, 10408, Republic of Korea.
  • Kim KH; Department of Cancer Biomedical Science, Graduate School of Cancer Science and Policy, National Cancer Center, Goyang, 10408, Republic of Korea.
  • Park BM; Immuno-oncology Branch, Division of Rare and Refractory Cancer, National Cancer Center, Goyang, 10408, Republic of Korea.
  • Shin DH; Department of Biomedical Laboratory Science, Catholic Kwandong University, Gangneung, 25601, Republic of Korea.
  • Han S; Severance Biomedical Science Institute, Brain Korea 21 Project for Medical Science, Yonsei University College of Medicine, Seoul, Republic of Korea.
  • Kim YH; Biomedicine Production Branch, Research Institute, National Cancer Center, Goyang, 10408, Republic of Korea.
  • Kwon BS; Department of Cancer Biomedical Science, Graduate School of Cancer Science and Policy, National Cancer Center, Goyang, 10408, Republic of Korea.
  • Nam KT; Anticancer Resistance Branch, Division of Rare and Refractory Cancer, Research Institute, National Cancer Center, Goyang, 10408, Republic of Korea.
  • Choi BK; Immuno-oncology Branch, Division of Rare and Refractory Cancer, National Cancer Center, Goyang, 10408, Republic of Korea.
Cell Mol Immunol ; 20(9): 1077-1080, 2023 09.
Article em En | MEDLINE | ID: mdl-37365325
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfócitos T CD8-Positivos / Ligante 4-1BB / Membro 9 da Superfamília de Receptores de Fatores de Necrose Tumoral Limite: Animals Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfócitos T CD8-Positivos / Ligante 4-1BB / Membro 9 da Superfamília de Receptores de Fatores de Necrose Tumoral Limite: Animals Idioma: En Ano de publicação: 2023 Tipo de documento: Article